img

Global 3rd Generation EGFR Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global 3rd Generation EGFR Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

3rd Generation EGFR report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 3rd Generation EGFR market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Lung Cancer and Liver Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 3rd Generation EGFR industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, 3rd Generation EGFR key manufacturers include Shanghai Allist Pharmaceuticals, Betta Pharmaceuticals and Nanjing Sanhome Pharmaceutical, etc. Shanghai Allist Pharmaceuticals, Betta Pharmaceuticals, Nanjing Sanhome Pharmaceutical are top 3 players and held % sales share in total in 2022.
3rd Generation EGFR can be divided into Monoclonal Antibody Class and Small Molecule Tyrosine Kinase Inhibitors (TKIs), etc. Monoclonal Antibody Class is the mainstream product in the market, accounting for % sales share globally in 2022.
3rd Generation EGFR is widely used in various fields, such as Lung Cancer, Liver Cancer, Stomach Cancer and Other, etc. Lung Cancer provides greatest supports to the 3rd Generation EGFR industry development. In 2022, global % sales of 3rd Generation EGFR went into Lung Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 3rd Generation EGFR market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Shanghai Allist Pharmaceuticals
Betta Pharmaceuticals
Nanjing Sanhome Pharmaceutical
Segment by Type
Monoclonal Antibody Class
Small Molecule Tyrosine Kinase Inhibitors (TKIs)

Segment by Application


Lung Cancer
Liver Cancer
Stomach Cancer
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the 3rd Generation EGFR market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 3rd Generation EGFR, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 3rd Generation EGFR industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of 3rd Generation EGFR in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 3rd Generation EGFR introduction, etc. 3rd Generation EGFR Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 3rd Generation EGFR market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 3rd Generation EGFR Market Overview
1.1 3rd Generation EGFR Product Overview
1.2 3rd Generation EGFR Market Segment by Type
1.2.1 Monoclonal Antibody Class
1.2.2 Small Molecule Tyrosine Kinase Inhibitors (TKIs)
1.3 Global 3rd Generation EGFR Market Size by Type
1.3.1 Global 3rd Generation EGFR Market Size Overview by Type (2018-2029)
1.3.2 Global 3rd Generation EGFR Historic Market Size Review by Type (2018-2024)
1.3.3 Global 3rd Generation EGFR Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America 3rd Generation EGFR Sales Breakdown by Type (2018-2024)
1.4.2 Europe 3rd Generation EGFR Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific 3rd Generation EGFR Sales Breakdown by Type (2018-2024)
1.4.4 Latin America 3rd Generation EGFR Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa 3rd Generation EGFR Sales Breakdown by Type (2018-2024)
2 Global 3rd Generation EGFR Market Competition by Company
2.1 Global Top Players by 3rd Generation EGFR Sales (2018-2024)
2.2 Global Top Players by 3rd Generation EGFR Revenue (2018-2024)
2.3 Global Top Players by 3rd Generation EGFR Price (2018-2024)
2.4 Global Top Manufacturers 3rd Generation EGFR Manufacturing Base Distribution, Sales Area, Product Type
2.5 3rd Generation EGFR Market Competitive Situation and Trends
2.5.1 3rd Generation EGFR Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by 3rd Generation EGFR Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 3rd Generation EGFR as of 2022)
2.7 Date of Key Manufacturers Enter into 3rd Generation EGFR Market
2.8 Key Manufacturers 3rd Generation EGFR Product Offered
2.9 Mergers & Acquisitions, Expansion
3 3rd Generation EGFR Status and Outlook by Region
3.1 Global 3rd Generation EGFR Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global 3rd Generation EGFR Historic Market Size by Region
3.2.1 Global 3rd Generation EGFR Sales in Volume by Region (2018-2024)
3.2.2 Global 3rd Generation EGFR Sales in Value by Region (2018-2024)
3.2.3 Global 3rd Generation EGFR Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global 3rd Generation EGFR Forecasted Market Size by Region
3.3.1 Global 3rd Generation EGFR Sales in Volume by Region (2024-2029)
3.3.2 Global 3rd Generation EGFR Sales in Value by Region (2024-2029)
3.3.3 Global 3rd Generation EGFR Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global 3rd Generation EGFR by Application
4.1 3rd Generation EGFR Market Segment by Application
4.1.1 Lung Cancer
4.1.2 Liver Cancer
4.1.3 Stomach Cancer
4.1.4 Other
4.2 Global 3rd Generation EGFR Market Size by Application
4.2.1 Global 3rd Generation EGFR Market Size Overview by Application (2018-2029)
4.2.2 Global 3rd Generation EGFR Historic Market Size Review by Application (2018-2024)
4.2.3 Global 3rd Generation EGFR Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America 3rd Generation EGFR Sales Breakdown by Application (2018-2024)
4.3.2 Europe 3rd Generation EGFR Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific 3rd Generation EGFR Sales Breakdown by Application (2018-2024)
4.3.4 Latin America 3rd Generation EGFR Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa 3rd Generation EGFR Sales Breakdown by Application (2018-2024)
5 North America 3rd Generation EGFR by Country
5.1 North America 3rd Generation EGFR Historic Market Size by Country
5.1.1 North America 3rd Generation EGFR Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America 3rd Generation EGFR Sales in Volume by Country (2018-2024)
5.1.3 North America 3rd Generation EGFR Sales in Value by Country (2018-2024)
5.2 North America 3rd Generation EGFR Forecasted Market Size by Country
5.2.1 North America 3rd Generation EGFR Sales in Volume by Country (2024-2029)
5.2.2 North America 3rd Generation EGFR Sales in Value by Country (2024-2029)
6 Europe 3rd Generation EGFR by Country
6.1 Europe 3rd Generation EGFR Historic Market Size by Country
6.1.1 Europe 3rd Generation EGFR Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe 3rd Generation EGFR Sales in Volume by Country (2018-2024)
6.1.3 Europe 3rd Generation EGFR Sales in Value by Country (2018-2024)
6.2 Europe 3rd Generation EGFR Forecasted Market Size by Country
6.2.1 Europe 3rd Generation EGFR Sales in Volume by Country (2024-2029)
6.2.2 Europe 3rd Generation EGFR Sales in Value by Country (2024-2029)
7 Asia-Pacific 3rd Generation EGFR by Region
7.1 Asia-Pacific 3rd Generation EGFR Historic Market Size by Region
7.1.1 Asia-Pacific 3rd Generation EGFR Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific 3rd Generation EGFR Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific 3rd Generation EGFR Sales in Value by Region (2018-2024)
7.2 Asia-Pacific 3rd Generation EGFR Forecasted Market Size by Region
7.2.1 Asia-Pacific 3rd Generation EGFR Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific 3rd Generation EGFR Sales in Value by Region (2024-2029)
8 Latin America 3rd Generation EGFR by Country
8.1 Latin America 3rd Generation EGFR Historic Market Size by Country
8.1.1 Latin America 3rd Generation EGFR Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America 3rd Generation EGFR Sales in Volume by Country (2018-2024)
8.1.3 Latin America 3rd Generation EGFR Sales in Value by Country (2018-2024)
8.2 Latin America 3rd Generation EGFR Forecasted Market Size by Country
8.2.1 Latin America 3rd Generation EGFR Sales in Volume by Country (2024-2029)
8.2.2 Latin America 3rd Generation EGFR Sales in Value by Country (2024-2029)
9 Middle East and Africa 3rd Generation EGFR by Country
9.1 Middle East and Africa 3rd Generation EGFR Historic Market Size by Country
9.1.1 Middle East and Africa 3rd Generation EGFR Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa 3rd Generation EGFR Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa 3rd Generation EGFR Sales in Value by Country (2018-2024)
9.2 Middle East and Africa 3rd Generation EGFR Forecasted Market Size by Country
9.2.1 Middle East and Africa 3rd Generation EGFR Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa 3rd Generation EGFR Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Shanghai Allist Pharmaceuticals
10.1.1 Shanghai Allist Pharmaceuticals Company Information
10.1.2 Shanghai Allist Pharmaceuticals Introduction and Business Overview
10.1.3 Shanghai Allist Pharmaceuticals 3rd Generation EGFR Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Shanghai Allist Pharmaceuticals 3rd Generation EGFR Products Offered
10.1.5 Shanghai Allist Pharmaceuticals Recent Development
10.2 Betta Pharmaceuticals
10.2.1 Betta Pharmaceuticals Company Information
10.2.2 Betta Pharmaceuticals Introduction and Business Overview
10.2.3 Betta Pharmaceuticals 3rd Generation EGFR Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Betta Pharmaceuticals 3rd Generation EGFR Products Offered
10.2.5 Betta Pharmaceuticals Recent Development
10.3 Nanjing Sanhome Pharmaceutical
10.3.1 Nanjing Sanhome Pharmaceutical Company Information
10.3.2 Nanjing Sanhome Pharmaceutical Introduction and Business Overview
10.3.3 Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Products Offered
10.3.5 Nanjing Sanhome Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 3rd Generation EGFR Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 3rd Generation EGFR Industrial Chain Analysis
11.4 3rd Generation EGFR Market Dynamics
11.4.1 3rd Generation EGFR Industry Trends
11.4.2 3rd Generation EGFR Market Drivers
11.4.3 3rd Generation EGFR Market Challenges
11.4.4 3rd Generation EGFR Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 3rd Generation EGFR Distributors
12.3 3rd Generation EGFR Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibody Class
Table 2. Major Company of Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Table 3. Global 3rd Generation EGFR Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global 3rd Generation EGFR Sales by Type (2018-2024) & (K Pcs)
Table 5. Global 3rd Generation EGFR Sales Market Share in Volume by Type (2018-2024)
Table 6. Global 3rd Generation EGFR Sales by Type (2018-2024) & (US& Million)
Table 7. Global 3rd Generation EGFR Market Share in Value by Type (2018-2024)
Table 8. Global 3rd Generation EGFR Price by Type (2018-2024) & (US$/Pcs)
Table 9. Global 3rd Generation EGFR Sales by Type (2024-2029) & (K Pcs)
Table 10. Global 3rd Generation EGFR Sales Market Share in Volume by Type (2024-2029)
Table 11. Global 3rd Generation EGFR Sales by Type (2024-2029) & (US$ Million)
Table 12. Global 3rd Generation EGFR Sales Market Share in Value by Type (2024-2029)
Table 13. Global 3rd Generation EGFR Price by Type (2024-2029) & (US$/Pcs)
Table 14. North America 3rd Generation EGFR Sales by Type (2018-2024) & (K Pcs)
Table 15. North America 3rd Generation EGFR Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe 3rd Generation EGFR Sales (K Pcs) by Type (2018-2024)
Table 17. Europe 3rd Generation EGFR Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific 3rd Generation EGFR Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific 3rd Generation EGFR Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America 3rd Generation EGFR Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America 3rd Generation EGFR Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa 3rd Generation EGFR Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa 3rd Generation EGFR Sales by Type (2018-2024) & (US$ Million)
Table 24. Global 3rd Generation EGFR Sales by Company (2018-2024) & (K Pcs)
Table 25. Global 3rd Generation EGFR Sales Share by Company (2018-2024)
Table 26. Global 3rd Generation EGFR Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global 3rd Generation EGFR Revenue Share by Company (2018-2024)
Table 28. Global Market 3rd Generation EGFR Price by Company (2018-2024) & (US$/Pcs)
Table 29. Global 3rd Generation EGFR Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global 3rd Generation EGFR Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 3rd Generation EGFR as of 2022)
Table 32. Date of Key Manufacturers Enter into 3rd Generation EGFR Market
Table 33. Key Manufacturers 3rd Generation EGFR Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global 3rd Generation EGFR Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global 3rd Generation EGFR Sales by Region (2018-2024) & (K Pcs)
Table 37. Global 3rd Generation EGFR Sales Market Share in Volume by Region (2018-2024)
Table 38. Global 3rd Generation EGFR Sales by Region (2018-2024) & (US$ Million)
Table 39. Global 3rd Generation EGFR Sales Market Share in Value by Region (2018-2024)
Table 40. Global 3rd Generation EGFR Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2018-2024)
Table 41. Global 3rd Generation EGFR Sales by Region (2024-2029) & (K Pcs)
Table 42. Global 3rd Generation EGFR Sales Market Share in Volume by Region (2024-2029)
Table 43. Global 3rd Generation EGFR Sales by Region (2024-2029) & (US$ Million)
Table 44. Global 3rd Generation EGFR Sales Market Share in Value by Region (2024-2029)
Table 45. Global 3rd Generation EGFR Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2024-2029)
Table 46. Global 3rd Generation EGFR Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global 3rd Generation EGFR Sales by Application (2018-2024) & (K Pcs)
Table 48. Global 3rd Generation EGFR Sales Market Share in Volume by Application (2018-2024)
Table 49. Global 3rd Generation EGFR Sales by Application (2018-2024) & (US$ Million)
Table 50. Global 3rd Generation EGFR Sales Market Share in Value by Application (2018-2024)
Table 51. Global 3rd Generation EGFR Price by Application (2018-2024) & (US$/Pcs)
Table 52. Global 3rd Generation EGFR Sales by Application (2024-2029) & (K Pcs)
Table 53. Global 3rd Generation EGFR Sales Market Share in Volume by Application (2024-2029)
Table 54. Global 3rd Generation EGFR Sales by Application (2024-2029) & (US$ Million)
Table 55. Global 3rd Generation EGFR Sales Market Share in Value by Application (2024-2029)
Table 56. Global 3rd Generation EGFR Price by Application (2024-2029) & (US$/Pcs)
Table 57. North America 3rd Generation EGFR Sales by Application (2018-2024) (K Pcs)
Table 58. North America 3rd Generation EGFR Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe 3rd Generation EGFR Sales by Application (2018-2024) (K Pcs)
Table 60. Europe 3rd Generation EGFR Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific 3rd Generation EGFR Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific 3rd Generation EGFR Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America 3rd Generation EGFR Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America 3rd Generation EGFR Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa 3rd Generation EGFR Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa 3rd Generation EGFR Sales by Application (2018-2024) & (US$ Million)
Table 67. North America 3rd Generation EGFR Sales by Country (2018-2024) & (K Pcs)
Table 68. North America 3rd Generation EGFR Sales Market Share in Volume by Country (2018-2024)
Table 69. North America 3rd Generation EGFR Sales by Country (2018-2024) & (US$ Million)
Table 70. North America 3rd Generation EGFR Sales Market Share in Value by Country (2018-2024)
Table 71. North America 3rd Generation EGFR Sales by Country (2024-2029) & (K Pcs)
Table 72. North America 3rd Generation EGFR Sales Market Share in Volume by Country (2024-2029)
Table 73. North America 3rd Generation EGFR Sales by Country (2024-2029) & (US$ Million)
Table 74. North America 3rd Generation EGFR Sales Market Share in Value by Country (2024-2029)
Table 75. Europe 3rd Generation EGFR Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe 3rd Generation EGFR Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe 3rd Generation EGFR Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe 3rd Generation EGFR Sales Market Share in Value by Country (2018-2024)
Table 79. Europe 3rd Generation EGFR Sales by Country (2024-2029) & (K Pcs)
Table 80. Europe 3rd Generation EGFR Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe 3rd Generation EGFR Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe 3rd Generation EGFR Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific 3rd Generation EGFR Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific 3rd Generation EGFR Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific 3rd Generation EGFR Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific 3rd Generation EGFR Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific 3rd Generation EGFR Sales by Region (2024-2029) & (K Pcs)
Table 88. Asia-Pacific 3rd Generation EGFR Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific 3rd Generation EGFR Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific 3rd Generation EGFR Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America 3rd Generation EGFR Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America 3rd Generation EGFR Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America 3rd Generation EGFR Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America 3rd Generation EGFR Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America 3rd Generation EGFR Sales by Country (2024-2029) & (K Pcs)
Table 96. Latin America 3rd Generation EGFR Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America 3rd Generation EGFR Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America 3rd Generation EGFR Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa 3rd Generation EGFR Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa 3rd Generation EGFR Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa 3rd Generation EGFR Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa 3rd Generation EGFR Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa 3rd Generation EGFR Sales by Country (2024-2029) & (K Pcs)
Table 104. Middle East and Africa 3rd Generation EGFR Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa 3rd Generation EGFR Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa 3rd Generation EGFR Sales Market Share in Value by Country (2024-2029)
Table 107. Shanghai Allist Pharmaceuticals Company Information
Table 108. Shanghai Allist Pharmaceuticals Introduction and Business Overview
Table 109. Shanghai Allist Pharmaceuticals 3rd Generation EGFR Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2018-2024)
Table 110. Shanghai Allist Pharmaceuticals 3rd Generation EGFR Product
Table 111. Shanghai Allist Pharmaceuticals Recent Development
Table 112. Betta Pharmaceuticals Company Information
Table 113. Betta Pharmaceuticals Introduction and Business Overview
Table 114. Betta Pharmaceuticals 3rd Generation EGFR Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2018-2024)
Table 115. Betta Pharmaceuticals 3rd Generation EGFR Product
Table 116. Betta Pharmaceuticals Recent Development
Table 117. Nanjing Sanhome Pharmaceutical Company Information
Table 118. Nanjing Sanhome Pharmaceutical Introduction and Business Overview
Table 119. Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Sales (K Pcs), Revenue (Million USD), Price (US$/Pcs) and Gross Margin (2018-2024)
Table 120. Nanjing Sanhome Pharmaceutical 3rd Generation EGFR Product
Table 121. Nanjing Sanhome Pharmaceutical Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. 3rd Generation EGFR Market Trends
Table 125. 3rd Generation EGFR Market Drivers
Table 126. 3rd Generation EGFR Market Challenges
Table 127. 3rd Generation EGFR Market Restraints
Table 128. 3rd Generation EGFR Distributors List
Table 129. 3rd Generation EGFR Downstream Customers
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. 3rd Generation EGFR Product Picture
Figure 2. Global 3rd Generation EGFR Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global 3rd Generation EGFR Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global 3rd Generation EGFR Sales Status and Outlook (2018-2029) & (K Pcs)
Figure 5. Product Picture of Monoclonal Antibody Class
Figure 6. Global Monoclonal Antibody Class Sales YoY Growth (2018-2029) & (K Pcs)
Figure 7. Product Picture of Small Molecule Tyrosine Kinase Inhibitors (TKIs)
Figure 8. Global Small Molecule Tyrosine Kinase Inhibitors (TKIs) Sales YoY Growth (2018-2029) & (K Pcs)
Figure 9. Global 3rd Generation EGFR Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global 3rd Generation EGFR Sales Market Share by Type in 2022 & 2029
Figure 11. North America 3rd Generation EGFR Sales Market Share in Volume by Type in 2022
Figure 12. North America 3rd Generation EGFR Sales Market Share in Value by Type in 2022
Figure 13. Europe 3rd Generation EGFR Sales Market Share in Volume by Type in 2022
Figure 14. Europe 3rd Generation EGFR Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific 3rd Generation EGFR Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific 3rd Generation EGFR Sales Market Share in Value by Type in 2022
Figure 17. Latin America 3rd Generation EGFR Sales Market Share in Volume by Type in 2022
Figure 18. Latin America 3rd Generation EGFR Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa 3rd Generation EGFR Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa 3rd Generation EGFR Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by 3rd Generation EGFR Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by 3rd Generation EGFR Revenue in 2022
Figure 23. 3rd Generation EGFR Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Lung Cancer
Figure 25. Global Lung Cancer Sales YoY Growth (2018-2029) & (K Pcs)
Figure 26. Product Picture of Liver Cancer
Figure 27. Global Liver Cancer Sales YoY Growth (2018-2029) & (K Pcs)
Figure 28. Product Picture of Stomach Cancer
Figure 29. Global Stomach Cancer Sales YoY Growth (2018-2029) & (K Pcs)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2018-2029) & (K Pcs)
Figure 32. Global 3rd Generation EGFR Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global 3rd Generation EGFR Sales Market Share by Application in 2022 & 2029
Figure 34. North America 3rd Generation EGFR Sales Market Share in Volume by Application in 2022
Figure 35. North America 3rd Generation EGFR Sales Market Share in Value by Application in 2022
Figure 36. Europe 3rd Generation EGFR Sales Market Share in Volume by Application in 2022
Figure 37. Europe 3rd Generation EGFR Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific 3rd Generation EGFR Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific 3rd Generation EGFR Sales Market Share in Value by Application in 2022
Figure 40. Latin America 3rd Generation EGFR Sales Market Share in Volume by Application in 2022
Figure 41. Latin America 3rd Generation EGFR Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa 3rd Generation EGFR Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. 3rd Generation EGFR Manufacturing Cost Structure
Figure 45. 3rd Generation EGFR Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed